ArticleJournal of orthopaedic case reports2024
A Rare Outcome of a Case of Medullary Osteosarcoma of the Femur in Ghana.
Article in Journal of orthopaedic case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteosarcoma is a malignant mesenchymal neoplasm in which the tumor cells produce defective and immature bone (osteoid). The risk factors for developing the disease include: Patients with hereditary retinoblastoma and germline mutations of the p53 tumor suppressor gene. Case Report: A 32-year old male presented with pain and swelling of the left thigh of 9 months duration. The pain was progressive, excruciating, worse at night, and unresponsive to paracetamol with moderate weight loss. He had sought treatment from a traditional bonesetter 6 months before presentation and had no improvement of the symptoms. Conclusion: In medullary osteosarcoma of the femur, where there is extracomparmental disease with no distant metastasis, clinically and radiologically, radical tumor resection with a free oncological margin increases survival of the patient up to 7 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.